{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:47:26Z","timestamp":1782128846310,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,22]]},"DOI":"10.7759\/cureus.111276","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:54:28Z","timestamp":1782125668000},"source":"Crossref","is-referenced-by-count":0,"title":["Natural Is Not Always Safe: A Case of Torsades De Pointes Induced by Berberine Supplementation"],"prefix":"10.7759","author":[{"given":"Jeremy M","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhita","family":"Yadlapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92354","article-title":"From misdiagnosis to recognition: torsades de pointes masquerading as non-sustained ventricular tachycardia","volume":"17","author":"Kommineni SK","year":"2025","unstructured":"Kommineni SK, Sherret J, Kondapaneni V, Vedantam V, Ramu V. From misdiagnosis to recognition: torsades de pointes masquerading as non-sustained ventricular tachycardia. Cureus. 2025, 17:e92354. 10.7759\/cureus.92354","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.1993.tb01224.x","article-title":"Drug therapy for torsade de pointes","volume":"4","author":"Banai S","year":"1993","unstructured":"Banai S, Tzivoni D. Drug therapy for torsade de pointes. J Cardiovasc Electrophysiol. 1993, 4:206-210. 10.1111\/j.1540-8167.1993.tb01224.x","journal-title":"J Cardiovasc Electrophysiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eum166","article-title":"Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes","volume":"9","author":"Antzelevitch C","year":"2007","unstructured":"Antzelevitch C. Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. Europace. 2007, 9:iv4-iv15. 10.1093\/europace\/eum166","journal-title":"Europace"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1363848","article-title":"Mechanisms of torsades de pointes: an update","volume":"11","author":"Tsuji Y","year":"2024","unstructured":"Tsuji Y, Yamazaki M, Shimojo M, Yanagisawa S, Inden Y, Murohara T. Mechanisms of torsades de pointes: an update. Front Cardiovasc Med. 2024, 11:1363848. 10.3389\/fcvm.2024.1363848","journal-title":"Front Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2020.05.002","article-title":"\"Off-label\" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers","volume":"75","author":"G\u00e9rard A","year":"2020","unstructured":"G\u00e9rard A, Romani S, Fresse A, et al.. \"Off-label\" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: a survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. Therapie. 2020, 75:371-379. 10.1016\/j.therap.2020.05.002","journal-title":"Therapie"},{"key":"ref6","article-title":"Torsade De Pointes","author":"Brian C","year":"2023","unstructured":"Brian C, Dov B. Torsade De Pointes. Mikhael F (ed): StatPearls, Treasure Island; 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00355.2007","article-title":"Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes","volume":"293","author":"Antzelevitch C","year":"2007","unstructured":"Antzelevitch C. Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. Am J Physiol Heart Circ Physiol. 2007, 293:H2024-H2038. 10.1152\/ajpheart.00355.2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01587.x","article-title":"Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes","volume":"259","author":"Antzelevitch C","year":"2006","unstructured":"Antzelevitch C, Oliva A. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med. 2006, 259:48-58. 10.1111\/j.1365-2796.2005.01587.x","journal-title":"J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12726","article-title":"Pharmacological treatment of acquired QT prolongation and torsades de pointes","volume":"81","author":"Thomas SH","year":"2016","unstructured":"Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016, 81:420-427. 10.1111\/bcp.12726","journal-title":"Br J Clin Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1002\/047002142X.ch16","article-title":"Cellular mechanisms of torsade de pointes","volume":"266","author":"Poelzing S","year":"2005","unstructured":"Poelzing S, Rosenbaum DS. Cellular mechanisms of torsade de pointes. Novartis Found Symp. 2005, 266:217-224.","journal-title":"Novartis Found Symp"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.17179\/excli2025-8771","article-title":"Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review","volume":"24","author":"Cheng H","year":"2025","unstructured":"Cheng H, Li X, Wang Y, et al.. Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review. EXCLI J. 2025, 24:1225-1261. 10.17179\/excli2025-8771","journal-title":"EXCLI J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i19.2842","article-title":"Inhibitory effects of berberine on ion channels of rat hepatocytes","volume":"10","author":"Wang F","year":"2004","unstructured":"Wang F, Zhou HY, Zhao G, Fu LY, Cheng L, Chen JG, Yao WX. Inhibitory effects of berberine on ion channels of rat hepatocytes. World J Gastroenterol. 2004, 10:2842-2845. 10.3748\/wjg.v10.i19.2842","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2011.00033","article-title":"Berberine reduces camp-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels","volume":"2","author":"Alzamora R","year":"2011","unstructured":"Alzamora R, O'Mahony F, Ko WH, Yip TW, Carter D, Irnaten M, Harvey BJ. Berberine reduces camp-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels. Front Physiol. 2011, 2:33. 10.3389\/fphys.2011.00033","journal-title":"Front Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2003.11.036","article-title":"Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus","volume":"999","author":"Wang F","year":"2004","unstructured":"Wang F, Zhao G, Cheng L, Zhou HY, Fu LY, Yao WX. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res. 2004, 999:91-97. 10.1016\/j.brainres.2003.11.036","journal-title":"Brain Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000363034","article-title":"Berberine induces hERG channel deficiency through trafficking inhibition","volume":"34","author":"Zhang K","year":"2014","unstructured":"Zhang K, Zhi D, Huang T, et al.. Berberine induces hERG channel deficiency through trafficking inhibition. Cell Physiol Biochem. 2014, 34:691-702. 10.1159\/000363034","journal-title":"Cell Physiol Biochem"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(25)04048-3","article-title":"Berberine induced torsades de pointes (TdP)","volume":"85","author":"Rafique S","year":"2025","unstructured":"Rafique S, Missula K, Cheema A, et al.. Berberine induced torsades de pointes (TdP). JACC. 2025, 85:3564. 10.1016\/S0735-1097(25)04048-3","journal-title":"JACC"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur316","article-title":"Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up","volume":"14","author":"M\u00f6nnig G","year":"2012","unstructured":"M\u00f6nnig G, K\u00f6be J, L\u00f6her A, et al.. Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up. Europace. 2012, 14:396-401. 10.1093\/europace\/eur316","journal-title":"Europace"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502235-natural-is-not-always-safe-a-case-of-torsades-de-pointes-induced-by-berberine-supplementation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:54:29Z","timestamp":1782125669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502235-natural-is-not-always-safe-a-case-of-torsades-de-pointes-induced-by-berberine-supplementation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.111276","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}